PNC Financial Services Group Inc. Has $852,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

PNC Financial Services Group Inc. lessened its stake in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) by 14.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,880 shares of the company’s stock after selling 1,529 shares during the period. PNC Financial Services Group Inc.’s holdings in HealthEquity were worth $852,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of HQY. GSA Capital Partners LLP bought a new position in HealthEquity in the 3rd quarter worth approximately $638,000. KBC Group NV grew its stake in shares of HealthEquity by 16.1% in the third quarter. KBC Group NV now owns 2,463 shares of the company’s stock worth $202,000 after acquiring an additional 341 shares during the last quarter. Natixis Advisors LLC increased its position in HealthEquity by 29.8% during the third quarter. Natixis Advisors LLC now owns 209,175 shares of the company’s stock worth $17,122,000 after acquiring an additional 48,009 shares during the period. Mutual of America Capital Management LLC raised its stake in HealthEquity by 0.7% during the 3rd quarter. Mutual of America Capital Management LLC now owns 97,718 shares of the company’s stock valued at $7,998,000 after purchasing an additional 648 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its holdings in HealthEquity by 33.3% in the 3rd quarter. Thrivent Financial for Lutherans now owns 293,624 shares of the company’s stock valued at $24,033,000 after purchasing an additional 73,404 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Trading Up 3.4 %

Shares of HealthEquity stock opened at $100.72 on Tuesday. The stock has a market capitalization of $8.73 billion, a P/E ratio of 92.40, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 12-month low of $65.01 and a 12-month high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a 50-day simple moving average of $105.76 and a 200 day simple moving average of $95.51.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. This represents a 6.85 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.20% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Royal Bank of Canada lifted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Barrington Research reissued an “outperform” rating and set a $112.00 price objective on shares of HealthEquity in a report on Friday. Wells Fargo & Company upped their target price on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Raymond James lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Finally, Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective for the company. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $112.92.

View Our Latest Stock Analysis on HQY

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.